The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed. What do you think?
The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed.
What do you think? Vote here and tell us more in the comments below.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.